News|Articles|October 25, 2026

Ebola Update: DRC Outbreak Reaches 9735 Cases, Second Largest on Record

Author(s)Matt Hoffman

CDC says the Bundibugyo virus outbreak in the DRC is the second-largest Ebola outbreak on record, with 9735 confirmed cases and 4690 deaths.

The Centers for Disease Control and Prevention (CDC) reported 9735 total confirmed cases and 4690 confirmed deaths as of October 21, 2026, in an Ebola outbreak caused by Bundibugyo virus. The agency said the outbreak is spreading substantially faster than previous Ebola outbreaks and is now the second-largest on record.1

The Democratic Republic of the Congo (DRC) accounts for 9704 confirmed cases and 4687 confirmed deaths. This is the 17th Ebola outbreak in the DRC, with cases confirmed in Bas-Uele, Haut-Uele, Ituri, North Kivu, South Kivu, South Ubangi, North Ubangi, and Tshopo provinces.1

Pace of Spread

The outbreak surpassed 1000 confirmed cases within 40 days of response activation. By comparison, the 2018 DRC outbreak took approximately 235 days to pass the same mark. South Kivu has reported no confirmed cases since May 29.1

Spread Beyond the DRC

Kenya has confirmed 9 cases and 1 death as of October 20. The first, on October 6, was a man who traveled from the DRC through Uganda to Nairobi, was hospitalized, and died in isolation; later cases were relatives or health care providers, all already in quarantine, and Kenya reports no community spread.1

Uganda reported 20 confirmed cases and 2 deaths, plus 1 probable case and 1 probable death, with its last reported case confirmed June 21. CDC also lists 1 confirmed case each in Nigeria and France.1

Risk to the United States and Travel Restrictions

CDC said no cases tied to this outbreak have been reported in the US and rates the overall risk to the American public as low. Travelers who were in the DRC within 21 days of their flight cannot board commercial flights to the US, and US citizens and nationals who were in Uganda or South Sudan, but not the DRC, must enter through designated airports for enhanced screening.1

Response Challenges

CDC cited limited health infrastructure, ongoing conflict, violence against health care workers, shortages of personal protective equipment, frequent cross-border travel, and misinformation as obstacles. Health care workers have become infected while treating patients.1

References
  1. Ebola Outbreak: Current Situation. CDC. October 22, 2026. Accessed October 23, 2026. https://www.cdc.gov/ebola/situation-summary/index.html

Related to this article

FAQ: Ebola Prevention, Treatment and the Chances of a US Outbreak
As the Bundibugyo virus outbreak in the Democratic Republic of the Congo surpasses 9300 confirmed cases and 4400 deaths, this FAQ explains how the virus spreads, how it presents, why it is hard to diagnose and treat, which vaccines and therapies are being tested, and why CDC considers the risk to the United States low.
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.